This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Aging is associated with a loss of muscle mass. Given the close association between muscle mass and bone mineral density (BMD), interventions to increase fat-free mass (FFM) in the elderly are necessary to prevent frailty and loss of functional independence. Furthermore, loss of muscle mass may predispose the older adult to obesity and Type 2 diabetes. Older adults can achieve significant increases in muscular strength in response to resistance exercise training (REX) but gains in FFM are typically modest (about 2 lbs or 1 kg) and less than those achieved by younger adults. The working model for the proposed study is that low levels of anabolic ('building') hormones in older adults limit the gains in FFM with REX. Dehydroepiandrosterone (DHEA) is a hormone secreted by the adrenal gland in diminishing amounts with advancing age. In previous studies, oral DHEA replacement (50 mg/day) increased blood DHEA-sulfate in older adults to young adult levels, and increased FFM and BMD. Thus the research hypothesis is that DHEA replacement in older adults will provide sufficient anabolic support to add to the increases in FFM and BMD in response to REX. To test this hypothesis, 20 healthy women and men, greater than 60 years old, will be recruited to complete a 6-month intervention of REX and DHEA replacement. The volunteers will have completed a 12-month study of DHEA replacement (GCRC protocol #1195) before starting REX. The volunteers were randomly assigned to take DHEA replacement (50 mg/day) or placebo. These assignments will continue for an additional 6 months, and will remain double-blinded. The study groups will be REX+DHEA and REX+placebo. REX will be 3 days per week, of high intensity (80% of maximum strength), using 7 exercises. Body composition will be determined by dual energy x-ray absorptiometry, computed tomography (CT) scans of the abdomen and mid-thigh areas, and circumference measurements. Muscle quality will be determined by one-repetition maximum strength tests, the Continuous-Scale Physical Functional Performance test, and oral glucose tolerance tests for insulin action. Changes in body composition and muscle quality in relation to serum levels of anabolic hormones and growth factors will be examined.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
2M01RR000051-46
Application #
7604388
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2007-07-01
Project End
2008-03-31
Budget Start
2007-07-01
Budget End
2008-03-31
Support Year
46
Fiscal Year
2007
Total Cost
$336
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Millstein, Richard J; Pyle, Laura L; Bergman, Bryan C et al. (2018) Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort. J Diabetes Complications 32:418-423
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Hayden, Kathleen M; Baker, Laura D; Bray, George et al. (2018) Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. Alzheimers Dement (Amst) 10:41-48
Shah, V N; Sippl, R; Joshee, P et al. (2018) Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance. Osteoporos Int 29:733-739
Jensen, Thomas; Bjornstad, Petter; Johnson, Richard J et al. (2018) Copeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI Study. Can J Diabetes :
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624

Showing the most recent 10 out of 1065 publications